Contact: +91-9711224068
International Journal of Applied Research
  • Multidisciplinary Journal
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal

ISSN Print: 2394-7500, ISSN Online: 2394-5869, CODEN: IJARPF

IMPACT FACTOR (RJIF): 8.4

Vol. 6, Issue 10, Part C (2020)

Study of capecitabine-An anticancer drug in dried blood spot

Study of capecitabine-An anticancer drug in dried blood spot

Author(s)
Faiyaz Ahmad
Abstract
Capecitabine (Cape), the main oral prodrug which has a place with the gathering of fluoropyrimidine is the most as often as possible recommended anticancer medication for the therapy of metastatic bosom and colorectal malignancies. The strategy was built up over a focus scope of 10-10000 ng/mL. Exactness, accuracy, selectivity, recuperation, lattice impact and soundness of the analyte were likewise assessed and results were inside the acknowledgment rules. Further, exact outcomes were gotten utilizing an ideal spot volume of 10 μL with great spot homogeneity. Blood tests with hematocrit esteems shifting from 24% to 45% gave worthy outcomes with great exactness and accuracy. The productivity of dried blood spot test arrangement, short investigation time and high selectivity grants assessment of Cape in a little blood volume. The approval results recommend that the strategy is exact, precise, and reproducible and can be valuable in restorative medication observing of Cape.
Pages: 126-129  |  450 Views  52 Downloads
How to cite this article:
Faiyaz Ahmad. Study of capecitabine-An anticancer drug in dried blood spot. Int J Appl Res 2020;6(10):126-129.
Call for book chapter
International Journal of Applied Research
Journals List Click Here Research Journals Research Journals